Related Experiment Video
Updated: Jul 15, 2025

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Construction and identification of lncRNA/circRNA-coregulated ceRNA networks in gemcitabine-resistant bladder
Jingjing Pan1, Xiaojuan Xie2, Jinxiu Sheng1
1Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University and the Key Clinical Laboratory of Henan Province, Zhengzhou, China.
Objectives:
To explore the regulatory networks that underlie the development of chemoresistance in bladder cancer.
Methods:
We analyzed profiles of differentially expressed long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), microRNAs (miRNAs) and messenger RNA (mRNAs) in gemcitabine-resistant/sensitive bladder cancer cells using next-generation sequencing data.
Results:
Hundreds of differentially expressed lncRNAs and miRNAs and thousands of circRNAs and mRNAs were identified. Bioinformatics analysis revealed the chromosomal localizations, classification and coexpression of mRNAs, as well as candidates for cis and trans regulation by lncRNAs. Furthermore, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis of differentially expressed mRNAs and circRNAs indicated important functional roles of coregulated RNAs, thus establishing competing endogenous RNA (ceRNA) and protein-protein interactions networks that may underlie chemoresistance in bladder cancer. We demonstrated that lncRNA LINP1 can act as a ceRNA by inhibiting miR-193a-5p to increase TP73 expression; and that lncRNA ESRG and hsa_circ_0075881 can simultaneously bind miR-324-3p to increase ST6GAL1 expression. Modulation of ceRNA network components using ablation and overexpression approaches contributed to gemcitabine resistance in bladder cancer cells.
Conclusions:
These results elucidate mechanisms by which lncRNAs and circRNAs coregulate the development of bladder cancer cell resistance to gemcitabine, thus laying the foundation for future research to identify biomarkers and disease targets.
Insights
Researchers uncovered regulatory networks involving long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) that drive chemoresistance in bladder cancer. These findings reveal key mechanisms and potential therapeutic targets for gemcitabine resistance.
Area of Science:
- Oncology
- Molecular Biology
- Genomics
Background:
- Chemoresistance is a major challenge in bladder cancer treatment.
- Understanding the molecular mechanisms of chemoresistance is crucial for developing effective therapies.
Purpose of the Study:
- To explore the regulatory networks underlying chemoresistance in bladder cancer.
- To identify key long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), microRNAs (miRNAs), and messenger RNAs (mRNAs) involved in gemcitabine resistance.
Main Methods:
- Differential expression analysis of lncRNAs, circRNAs, miRNAs, and mRNAs in gemcitabine-resistant/sensitive bladder cancer cells using next-generation sequencing.
- Bioinformatics analysis including chromosomal localization, classification, coexpression, and cis/trans regulation.
- Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis.
- Construction of competing endogenous RNA (ceRNA) and protein-protein interaction networks.
Main Results:
- Hundreds of differentially expressed lncRNAs and miRNAs, and thousands of circRNAs and mRNAs were identified.
- Bioinformatics analysis revealed complex regulatory networks and functional roles of coregulated RNAs.
- Specific examples include lncRNA LINP1 acting as a ceRNA for miR-193a-5p to increase TP73 expression, and lncRNA ESRG and hsa_circ_0075881 binding miR-324-3p to increase ST6GAL1 expression.
- Modulation of ceRNA network components affected gemcitabine resistance in bladder cancer cells.
Conclusions:
- Elucidated mechanisms of lncRNA and circRNA coregulation in bladder cancer gemcitabine resistance.
- Established the foundation for identifying novel biomarkers and therapeutic targets for bladder cancer chemoresistance.
Related Concept Videos
lncRNA - Long Non-coding RNAs
The Nucleolus

